Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Flutamide and finasteride reduced sex hormones in pregnant hyenas, but increased them in males.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Androgens, like testosterone, are crucial for early testicular descent in rats.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Testosterone with or without finasteride doesn't improve thinking skills in older men with low testosterone.

Finasteride doesn't affect bone density in male rats.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Finasteride doesn't affect bone density in male rats.

Researchers developed a new, precise method to measure hair loss in mice using image analysis.

Flutamide rarely causes liver toxicity in prostate cancer patients.

The document concludes that a man's long hair may have helped diagnose his rare case of chronic hair shedding, for which no treatment is advised.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

The EFH-SLM cream is more effective and gentler for treating excessive hair growth in women.

Spironolactone was effective in reducing hair growth in women with hirsutism.